| |
| |
|
| Insider
Information: |
Vig Pamela |
| Relationship: |
|
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
28,691 |
|
|
Indirect Shares
|
75,000 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
103,691 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mirum Pharmaceuticals, Inc. |
MIRM |
|
2024-02-02 |
28,691 |
2024-02-02 |
75,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MIRM |
Mirum Pharmaceuticals, In... |
CHIEF SCIENTIFIC OFFICER |
• – – |
2024-02-02 |
4 |
S |
$26.19 |
$31,797 |
D/D |
(1,214) |
28,691 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
HEAD OF RESEARCH & DEVELOPMENT |
• – – |
2024-01-08 |
4 |
S |
$28.03 |
$39,472 |
D/D |
(1,408) |
29,905 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Head of Research & Development |
• – – |
2023-11-10 |
4 |
A |
$22.29 |
$11,745 |
D/D |
527 |
31,313 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Head of Research & Development |
• – – |
2023-07-03 |
4 |
S |
$25.65 |
$36,546 |
D/D |
(1,425) |
30,786 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Head of Research & Development |
• – – |
2023-05-10 |
4 |
A |
$16.92 |
$11,576 |
D/D |
684 |
32,211 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Head of Research & Development |
• – – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,625 |
31,527 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
CHIEF SCIENTIFIC OFFICER |
• – – |
2023-01-09 |
4 |
S |
$20.62 |
$28,438 |
D/D |
(1,379) |
27,312 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Head of Research & Development |
• – – |
2022-11-10 |
4 |
A |
$17.05 |
$11,254 |
D/D |
660 |
21,902 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Head of Research & Development |
• – – |
2022-05-10 |
4 |
A |
$13.57 |
$10,948 |
D/D |
807 |
21,242 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2022-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
20,435 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2021-11-10 |
4 |
A |
$13.52 |
$10,380 |
D/D |
768 |
10,435 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2021-10-01 |
4 |
S |
$19.26 |
$26,265 |
D/D |
(1,364) |
9,667 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2021-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
8,125 |
11,031 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2021-05-10 |
4 |
A |
$14.62 |
$10,219 |
D/D |
699 |
2,906 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2020-11-10 |
4 |
A |
$15.27 |
$9,083 |
D/D |
595 |
2,207 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2019-09-06 |
4 |
B |
$10.96 |
$17,682 |
D/D |
1,612 |
1,612 |
2.74 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
Chief Scientific OfficerOffice |
• – – |
2019-07-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
75,000 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
